Duchenne News Tags: Precision Biosciences

July 29, 2025
On July 16, 2025, Precision BioSciences, Inc. announced updated additional preclinical data further validating the scientific rationale supporting the rapid development of PBGENE-DMD, the Company’s first-in-class in vivo gene editing approach for...